{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:35:58Z","timestamp":1778276158990,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1803125"],"award-info":[{"award-number":["U1803125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150732","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T06:22:28Z","timestamp":1726899748000},"page":"150732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Naringenin ameliorates MASH fibrosis via regulating TAK1\/MAPK\/FoxO3a-mediated apoptosis in the activated hepatic stellate cells"],"prefix":"10.1016","volume":"734","author":[{"given":"Ze-jiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-tong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-kang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150732_bib1","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150732_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150732_bib3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.150732_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1126\/science.270.5244.2008","article-title":"Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction","volume":"270","author":"Yamaguchi","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150732_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.32221","article-title":"Breviscapine alleviates NASH by inhibiting TGF-beta-activated kinase 1-dependent signaling","volume":"76","author":"Lan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150732_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108306","article-title":"Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1\/AMPK signaling","volume":"104","author":"Liang","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bbrc.2024.150732_bib7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/hep.32213","article-title":"Switch-associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1","volume":"75","author":"Qian","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150732_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.freeradbiomed.2020.04.009","article-title":"Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1","volume":"153","author":"Wu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2024.150732_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s11010-022-04369-5","article-title":"TGF-beta activates NLRP3 inflammasome by an autocrine production of TGF-beta in LX-2 human hepatic stellate cells","volume":"477","author":"Kang","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2024.150732_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-020-0088-2","article-title":"Therapeutic strategies targeting FOXO transcription factors","volume":"20","author":"Calissi","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.150732_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107338","article-title":"Role of Forkhead box O3a transcription factor in autoimmune diseases","volume":"92","author":"Xu","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bbrc.2024.150732_bib12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.31832","article-title":"Tumor necrosis factor alpha-induced protein 8-like 2 alleviates nonalcoholic fatty liver disease through suppressing transforming growth factor beta-activated kinase 1 activation","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150732_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/toxsci\/kfaa185","article-title":"Transforming growth factor beta-induced Foxo3a acts as a profibrotic mediator in hepatic stellate cells","volume":"179","author":"Kim","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbrc.2024.150732_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2014.11.040","article-title":"The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0\/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K\/Akt\/FOXO3a signaling pathway","volume":"747","author":"Li","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150732_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113021","article-title":"Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFbeta\/Smad and Akt\/FoxO3 signaling pathways based on network pharmacology analysis","volume":"264","author":"Zhou","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2024.150732_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389201015666141202110216","article-title":"Naringenin and atherosclerosis: a review of literature","volume":"16","author":"Orhan","year":"2015","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.150732_bib17","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3748\/wjg.v23.i24.4354","article-title":"Naringenin prevents experimental liver fibrosis by blocking TGFbeta-Smad3 and JNK-Smad3 pathways","volume":"23","author":"Hernandez-Aquino","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2024.150732_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172730","article-title":"Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways","volume":"865","author":"Hernandez-Aquino","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150732_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153412","article-title":"Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe(-\/-)mice: role of SIRT1","volume":"81","author":"Hua","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2024.150732_bib20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-kappaB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150732_bib21","first-page":"26","article-title":"Naringenin is a potential immunomodulator for inhibiting liver fibrosis by inhibiting the cGAS-STING pathway","volume":"11","author":"Chen","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.bbrc.2024.150732_bib22","article-title":"XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression","volume":"4","author":"Wang","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.bbrc.2024.150732_bib23","doi-asserted-by":"crossref","first-page":"90892","DOI":"10.1007\/s11356-023-28454-4","article-title":"Naringin and naringenin counteract taxol-induced liver injury in Wistar rats via suppression of oxidative stress, apoptosis and inflammation","volume":"30","author":"Khaled","year":"2023","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.bbrc.2024.150732_bib24","article-title":"Naringenin induces HepG2 cell apoptosis via ROS-mediated JAK-2\/STAT-3 signaling pathways","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2024.150732_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jcb.25729","article-title":"Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the PI3K\/AKT and MAPK signaling pathways","volume":"118","author":"Lim","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2024.150732_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","article-title":"Critical role of FOXO3a in carcinogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2024.150732_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215724","article-title":"FOXO3a in cancer drug resistance","volume":"540","author":"Liu","year":"2022","journal-title":"Cancer Lett."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24012683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T19:32:45Z","timestamp":1732649565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24012683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"alternative-id":["S0006291X24012683"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150732","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naringenin ameliorates MASH fibrosis via regulating TAK1\/MAPK\/FoxO3a-mediated apoptosis in the activated hepatic stellate cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150732"}}